WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006088954) DIHYDROINDOLYL METHANONES AS ALPHA 1A/1D ADRENORECEPTOR MODULATORS FOR THE TREATMENT OF BENIGN PROSTATIC HYPERTROPHY AND LOWER URINARY TRACT SYMPTOMS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/088954    International Application No.:    PCT/US2006/005326
Publication Date: 24.08.2006 International Filing Date: 14.02.2006
IPC:
A61K 31/454 (2006.01), A61K 31/496 (2006.01), C07D 401/10 (2006.01), C07D 403/10 (2006.01)
Applicants: JANSSEN PHARMACEUTICA, N.V. [BE/BE]; Turnhoutseweg 30, B-2340 Beerse (BE) (For All Designated States Except US).
BAXTER, Ellen, W. [US/US]; (US) (For US Only).
NORTEY, Samuel, O. [US/US]; (US) (For US Only).
REITZ, Allen, B. [US/US]; (US) (For US Only).
PULITO, Virginia, L. [US/US]; (US) (For US Only).
MIDDLETON, Steven, A. [US/US]; (US) (For US Only)
Inventors: BAXTER, Ellen, W.; (US).
NORTEY, Samuel, O.; (US).
REITZ, Allen, B.; (US).
PULITO, Virginia, L.; (US).
MIDDLETON, Steven, A.; (US)
Agent: JOHNSON, Philip, S.; One Johnson & Johnson Plaza, New Brunswick, NJ 08933 (US)
Priority Data:
60/653,218 15.02.2005 US
Title (EN) DIHYDROINDOLYL METHANONES AS ALPHA 1A/1D ADRENORECEPTOR MODULATORS FOR THE TREATMENT OF BENIGN PROSTATIC HYPERTROPHY AND LOWER URINARY TRACT SYMPTOMS
(FR) DIHYDROINDOLYL METHANONES UTILISEES EN TANT QUE MODULATEURS DE L'ADRENORECEPTEUR ALPHA 1A/1D POUR LE TRAITEMENT DE L'HYPERTROPHIE BENIGNE DE LA PROSTATE ET LES SYMPTOMES DES VOIES URINAIRES INFERIEURES
Abstract: front page image
(EN)The present invention relates to new compounds of Formula (I) and pharmaceutically acceptable forms thereof, use of the compounds as &agr;1a and/or &agr;1d adrenoreceptor modulators, including use of a pharmaceutical composition, medicine or medicament comprising said compounds, a process to prepare said compounds and a method for treating an &agr;1a and/or &agr;1d adrenoreceptor mediated disorder.
(FR)La présente invention concerne de nouveaux composés représentés par la formule (I) et des formes pharmaceutiquement acceptables de ces derniers, l'utilisation de ces composés en tant que modulateurs de l'adrénorécepteur a1a et/ou a1d, l'utilisation d'une composition pharmaceutique, d'une médication ou d'un médicament renfermant lesdits composés, un procédé de préparation des composés selon l'invention et une méthode de traitement d'un trouble médié par l'adrénorécepteur a1a et/ou a1d.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)